AKT1 inhibitory dnazymes inhibit cell proliferation and migration of thyroid cancer cells

Asian Pacific Journal of Cancer Prevention

Volumn 14, Issue 4, 2013, Pages 2571-2575

  Yang, Le ^a   He, Jin Ting ^b   Guan, Hong ^a   Sun, Ya Dong ^a  

^a Jilin Province People's Hospital   (China)

^b JILIN UNIVERSITY   (China)

Author keywords

AKT1; Apoptosis; DNAzymes; Proliferation; Thyroid cancer

Indexed keywords

EID: 84880306910     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: 10.7314/APJCP.2013.14.4.2571     Document Type: Article

References (17)

1. Cheng S, Niv MY (2010). Molecular dynamics simulations and elastic network analysis of protein kinase B (Akt/PKB) inactivation. J Chem Inf Model, 50, 1602-10.
2. Gijsen M, King P, Perera T, et al (2010). HER2 phosphorylation is maintained by a PKB negative feedback loop in response to anti-HER2 herceptin in breast cancer. PLoS Biol, 8, e1000563.
3. Hollenstein M, Hipolito C, Lam C, Perrin D (2008). In vitro selection of a DNAzyme with three modified nucleotides. Nucleic Acids Symp Ser (Oxf), 2008, 73-4.
4. Hou P, Liu D, Shan Y, Hu S, et al (2007). Genetic alterations and their relationship in the phosphatidylinositol 3-kinase/Akt pathway in thyroid cancer. Clin Cancer Res, 13, 1161-70.
5. Li Y, Sen D (1997). Toward an efficient DNAzyme. Biochemistry, 36, 5589-99.
6. Kucukalic-Selimovic E, Alagic J, Valjevac A, et al (2012). The Akt inhibitor MK2206 synergizes, but perifosine antagonizes, the BRAF(V600E) inhibitor PLX4032 and the MEK1/2 inhibitor AZD6244 in the inhibition of thyroid cancer cells. J Clin Endocrinol Metab, 97, E173-82.
7. Kucukalic-Selimovic E, Alagic J, Valjevac A, et al (2012). The value of serum thyreoglobulin levels and whole body (I-131) scintigraphy in the follow-up of the thyroid cancer patients after thyroidectomy. Coll Antropol, 36, 67-71.
8. Mansley MK, Wilson SM (2010). Effects of nominally selective inhibitors of the kinases PI3K, SGK1 and PKB on the insulin-dependent control of epithelial Na+ absorption. Br J Pharmacol, 161, 571-88.
9. Mo N, Li ZQ, Li J, Cao YD (2012). Curcumin Inhibits TGFbeta1-Induced MMP-9 and Invasion through ERK and Smad Signaling in Breast Cancer MDA-MB-231 Cells. Asian Pac J Cancer Prev, 13, 5709-14.
10. Pitt S C, Chen H (2008). The phosphatidylinositol 3-kinase/akt signaling pathway in medullary thyroid cancer. Surgery, 144, 721-4.
11. Ponce D, Maturana JL, Cabello P, et al (2010). Phosphorylation of AKT/PKB by CK2 is necessary for the AKT-dependent up-regulation of beta-catenin transcriptional activity. J Cell Physiol, 226, 1953-9.
12. Tang M, Iijima M, Kamimura Y, et al (2011). Disruption of PKB signaling restores polarity to cells lacking tumor suppressor PTEN. Mol Biol Cell, 22, 437-47.
13. Taskin S, Dünder I, Erol E, et al (2012). Roles of E-cadherin and cyclooxygenase enzymes in predicting different survival patterns of optimally cytoreduced serous ovarian cancer patients. Asian Pac J Cancer Prev, 13, 5715-9.
14. Tian Y, Mao C (2005). DNAzyme amplification of molecular beacon signal. Talanta, 67, 532-7.
15. Verma N, Tripathi SK, Chaudhury I, et al (2010). iNOStargeted 10-23 DNAzyme reduces LPS-induced systemic inflammation and mortality in mice. Shock, 33, 493-9.
16. Wang TH, Li WT, Yu SH, et al (2008). The use of 10-23 DNAzyme to selectively destroy the allele of mRNA with a unique purine-pyrimidine dinucleotide. Oligonucleotides, 18, 295-9.
17. Zhao ZG, Guo XG, Ba CX, et al (2012). Overweight, Obesity and Thyroid Cancer Risk, a Meta-analysis of Cohort Studies. J Int Med Res, 40, 2041-50.